🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Drug: Ivonescimab Injection

    Summit Therapeutics

    Metastatic Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  2. Duloxetine hydrochloride

    Eli Lilly and Company

    Diabetic Neuropathies

    phase 3 small molecule completed

    1 trial

  3. Dupilumab

    Regeneron UK Limited

    Eosinophilic Esophagitis (EoE)

    phase 3 small molecule active

    2 trials

  4. Dupilumab

    Regeneron UK Limited

    Prurigo Nodularis

    phase 3 small molecule active

    1 trial

  5. Dupilumab

    Regeneron UK Limited

    Lichen Simplex Chronicus

    phase 3 small molecule active

    2 trials

  6. Dupilumab

    Regeneron UK Limited

    Wheezing

    phase 3 small molecule active

    1 trial

  7. Dupilumab Prefilled Syringe

    Regeneron UK Limited

    Asthma Control

    phase 3 small molecule active

    1 trial

  8. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Rhinosinusitis Without Nasal Polyps

    phase 3 small molecule completed

    1 trial

  9. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule completed

    2 trials

  10. Dupilumab SAR231893

    Regeneron UK Limited

    Allergic Fungal Rhinosinusitis

    phase 3 small molecule completed

    1 trial

  11. Dupilumab SAR231893

    Regeneron UK Limited

    Neurodermatitis

    phase 3 small molecule completed

    2 trials

  12. Dupilumab SAR231893

    Regeneron UK Limited

    Cold Urticaria

    phase 3 small molecule completed

    1 trial

  13. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Spontaneous Urticaria

    phase 3 small molecule completed

    1 trial

  14. Dupilumab SAR231893

    Regeneron UK Limited

    Asthma

    phase 3 small molecule completed

    1 trial

  15. Dupilumab SAR231893 (REGN668)

    Regeneron UK Limited

    Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

    phase 3 small molecule completed

    2 trials

  16. Dupilumab SAR231893 (REGN668)

    Regeneron UK Limited

    Asthma

    phase 3 small molecule completed

    2 trials

  17. Dupilumab, Matched placebo for test product

    Sanofi-aventis Healthcare Pty Ltd

    Neurodermatitis

    phase 3 small molecule active

    1 trial

  18. Dupilumab, Matched placebo for test product

    Sanofi-aventis Healthcare Pty Ltd

    Neurodermatitis

    phase 3 small molecule active

    1 trial

  19. Durvalumab

    AstraZeneca

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    1 trial

  20. Durvalumab

    AstraZeneca

    Locally Advanced Cervical Cancer

    phase 3 mab completed

    1 trial

  21. Durvalumab

    AstraZeneca

    Non-Small Cell Lung Cancer

    phase 3 small molecule active

    2 trials

  22. Durvalumab

    AstraZeneca

    Cancer

    phase 3 small molecule active

    1 trial

  23. Durvalumab

    Arcus Biosciences

    Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  24. Durvalumab

    AstraZeneca

    Hepatocellular Carcinoma

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources